Osimertinib as First-line Therapy for Patients With Late-stage Lung Cancer
Clinical trial NCT03460275 · UNKNOWN
Trial details
- NCT number
- NCT03460275
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-26
- Primary completion
- 2020-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.